Early versus late surgery for ileo-caecal Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 10, 2007, Pages 1303-1312

  Aratari, A ^a   Papi, C ^b   Leandro, G ^c   Viscido, A ^a   Capurso, L ^b   Caprilli, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; COLON CROHN DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE SURGERY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CECAL DISEASES; CHILD; CROHN DISEASE; FEMALE; HUMANS; ILEAL DISEASES; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 35748974809     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03515.x     Document Type: Review

References (42)

1. Shivananda S, Hordijk ML, Pena AS, Mayberry JF. Crohn's disease: risk of recurrence and re-operation in a defined population. Gut 1989 30 : 990 5.
2. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand 1979 490 (Suppl. 1 84.
3. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000 231 : 38 45.
4. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995 30 : 699 706.
5. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in Southeaster Norway, 1990-93. Scand J Gastroenterol 1997 32 : 1005 12.
6. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000 35 : 1272 7.
7. Michelassi F, Balestracci T, Chappel R, et al. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991 214 : 230 40.
8. Louis E, Collard A, Oger AF, Degroote E, El Yafi FAN, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001 49 : 777 82.
9. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002 8 : 244 50.
10. Papi C, Festa V, Fagnani C, et al. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Digest Liver Dis 2005 37 : 247 53.
11. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984 25 : 665 72.
12. Borley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn's disease. Br J Surg 1997 84 : 1493 502.
13. Cottone M, Orlando A, Viscido A, Calabrese E, Camma C, Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003 17 (Suppl. 2 38 42.
14. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994 8 : 35 43.
15. Cammà C, Giunta M, Rosselli M, Cottone M. 5-aminosalicylic acid in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997 113 : 1465 73.
16. Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 2000 119 : 597.
17. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999 117 : 49 57.
18. Krause U. Early or late operation in the treatment of Crohn's disease. Scand J Gastroenterol 1971 6 : 479 81.
19. Alexander-Williams J. Surgical aspects of inflammatory bowel disease. Scand J Gastroenterol 1990 172 : 39 42.
20. Hulten L. Surgical management and strategy in classical Crohn's disease. Int Surg 1992 77 : 2 8.
21. Lindhagen T, Ekelund GT, Leandor L, Hildell J, Lindstrom C, Wenckert A. Pre and Post-operative complications in Crohn's disease with special reference to duration of preoperative disease history. Scand J Gastroenterol 1984 19 : 194 203.
22. Weston LA, Roberts PL, Schoetz DJ Jr., Coller JA, Murray JJ, Rusin LC. Ileocolic resection for acute presentation of Crohn's disease of the ileum. Dis Colon Rectum 1996 39 : 841 6.
23. Andrews HA, Keighley MRB, Alexander-Williams J, Allan RN. Strategy for management of distal ileal Crohn's disease. Br J Surg 1991 78 : 679 82.
24. Windsor ACJ. Ileal Crohn's disease is best treated by surgery. Gut 2002 51 : 11 2.
25. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994 106 : 287 96.
26. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther 2002 16 : 1603 9.
27. Thirlby RC, Land JC, Fenster LF, Lonborg R. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg 1998 133 : 826 32.
28. Hulten L. Surgical treatment of Crohn's disease of the small bowel or ileocecum. World J Surg 1988 12 : 180 5.
29. Fast S, Helleberg R, Hulten L, Magnusson O. Early complications after surgical treatment for Crohn's disease with particular reference to factors affecting their development. Acta Chir Scand 1980 146 : 519.
30. Scott NA, Hughes LE. Timing of ileocolonic resection for symptomatic Crohn's disease - the patient's view. Gut 1994 35 : 656 7.
31. Siassi M, Weiger A, Hohenberger W, Kessler H. Change in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study. Int J Colorectal Dis 2007 22 : 319 24.
32. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005 54 : 237 41.
33. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocecal Crohn's disease. Br J Surg 2000 87 : 1697 701.
34. Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001 7 : 306 13.
35. Cottone M, Roselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994 106 : 643 8.
36. Yamamoto T, Keighley MRB. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000 87 : 398 404.
37. Birrenbach T, Bocker U. Inflammatory disease and smoking. A review of epidemiology, pathophysiology and therapeutic implications. Inflamm Bowel Dis 2004 10 : 848 59.
38. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988 29 : 588 92.
39. Yamamoto T, Allan RN, Keighley MR. Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease. Dis Colon Rectum 1999 42 : 519 24.
40. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005 11 : 3971 9.
41. Kennedy ED, Urbach DR, Krahn MD, Steinhart AH, Cohen Z, McLeod RS. Azathioprine or ileocolonic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis. Dis Colon Rectum 2004 47 : 2120 30.
42. Travis SP, Stange EF, Lémman M, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006 55 (Suppl. 1 i16 35.